Novacyt Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Lyn Rees
Chief executive officer
UK£336.1k
Total compensation
CEO salary percentage | 31.0% |
CEO tenure | less than a year |
CEO ownership | n/a |
Management average tenure | less than a year |
Board average tenure | 1.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -UK£37m |
Mar 31 2024 | n/a | n/a | -UK£33m |
Dec 31 2023 | UK£336k | UK£104k | -UK£28m |
Compensation vs Market: Lyn's total compensation ($USD422.64K) is about average for companies of similar size in the German market ($USD466.27K).
Compensation vs Earnings: Insufficient data to compare Lyn's compensation with company performance.
CEO
Lyn Rees (51 yo)
less than a year
Tenure
UK£336,106
Compensation
Mr. Lyn Dafydd Rees serves as Executive Director at Novacyt S. A. since September 2023 and serves as its Chief Executive Officer since May 01, 2024. He serves as Non-Executive Director at MyHealthChecked P...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Executive Director | less than a year | UK£336.11k | no data | |
CFO & Director | less than a year | no data | no data | |
Chief Operations Officer | 2.9yrs | no data | no data | |
Chief Scientific Officer & Director | less than a year | no data | no data | |
Chief Human Resources Officer | 3.7yrs | no data | no data | |
Group Head of R&D | no data | no data | no data |
0.9yrs
Average Tenure
Experienced Management: NYZ's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Executive Director | 1.3yrs | UK£336.11k | no data | |
CFO & Director | less than a year | no data | no data | |
Chief Scientific Officer & Director | less than a year | no data | no data | |
Non-Executive Chairman | 1.3yrs | UK£15.24k | no data | |
Independent Non-Executive Director | 7.5yrs | UK£48.93k | no data | |
Independent Non-Executive Director | no data | UK£34.04k | 0.048% € 20.9k | |
Member of Scientific Committee | no data | no data | no data | |
Member of Scientific Committee | no data | no data | no data | |
Member of Scientific Committee | no data | no data | no data | |
Member of Scientific Committee | no data | no data | no data |
1.3yrs
Average Tenure
54.5yo
Average Age
Experienced Board: NYZ's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/20 03:04 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Novacyt S.A. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Mathieu Jasmin | Arkeon Finance |
Johann Carrier | Invest Securities |
Stefan Hamill | Numis Securities Ltd. |